GWPH News Alert Gw Pharmaceuticals Plc Ads (GWPH) 68.08 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gw Pharmaceuticals Plc Ads (GWPH) 68.08 $GWPH

'Mad Money' Lightning Round: SunTrust Banks Is Terrific
at The Street - Wed Dec 24, 5:00AM CST
Cramer says by GW Pharmaceuticals for the long term but avoid Arlington Asset Management and Prospect Capital.
EYES: 11.01 (+0.86), GWPH: 68.08 (+1.82), COG: 30.21 (-0.39), STI: 42.43 (-0.18), AI: 27.70 (-0.12), BMY: 59.15 (-0.01), RRC: 55.73 (-1.27), PSEC: 8.59 (-0.02)

Cramer's Lightning Round - GW Pharmaceuticals Is A Great Stock For The Long Term (12/23/14)
SA Editor Miriam Metzinger - at Seeking Alpha - Wed Dec 24, 4:41AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday December 23. Bullish Calls: GW Pharmaceuticals (NASDAQ: GWPH ): "It is very speculative, but it is a hold for the long term. GWPH has these...
EYES: 11.01 (+0.86), COG: 30.21 (-0.39), GWPH: 68.08 (+1.82), STI: 42.43 (-0.18), AI: 27.70 (-0.12), PSEC: 8.59 (-0.02)

Jim Cramer's 'Mad Money' Recap: Here Are 10 Stocks to Buy on Strong GDP Data
at The Street - Tue Dec 23, 7:26PM CST
Kimberly-Clark, Walgreen and Starbucks are among Cramer's winners on today's GDP number.
RH: 96.97 (-0.16), EYES: 11.01 (+0.86), ETN: 69.30 (-0.09), HON: 101.96 (-0.02), KMB: 117.77 (-0.21), IBB: 299.80 (+5.12), BMY: 59.15 (-0.01), PLKI: 55.50 (+0.01), MAR: 78.35 (-0.19), BA: 131.24 (+1.21), RRC: 55.73 (-1.27), VSAT: 63.75 (-0.20), SBUX: 81.27 (-0.16), NVGS: 20.00 (+2.10), COG: 30.21 (-0.39), GILD: 91.29 (+1.84), GWPH: 68.08 (+1.82), STI: 42.43 (-0.18), COST: 143.65 (-0.50), AI: 27.70 (-0.12), WAG: 76.67 (+0.16), PSEC: 8.59 (-0.02), EPD: 35.45 (+0.25)

3 Drugmakers Facing a Pivotal 2015
George Budwell, The Motley Fool - Motley Fool - Mon Dec 22, 10:41AM CST
Source: www.bio.org Pharmaceutical companies have been some of the best performing stocks lately due to the confluence of an aging U.S. population and new regulatory avenues within the Food and Drug Administration that have led to an uptick in drug...
BIIB: 340.89 (+5.13), ISIS: 59.49 (+1.88), GWPH: 68.08 (+1.82), AZN: 70.44 (+0.26), IBB: 299.80 (+5.12), PTCT: 51.66 (+0.76), GSK: 42.85 (+0.11)

GW Pharmaceuticals Added to NASDAQ Biotechnology Index
GlobeNewswire - Mon Dec 22, 1:00AM CST
GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective at the open of U.S. markets today.
GWPH: 68.08 (+1.82), IBB: 299.80 (+5.12)

Could the Next Generation of Diabetes Treatments Be Found in This Illegal Drug?
Sean Williams, The Motley Fool - Motley Fool - Sun Dec 21, 10:41AM CST
Heart disease and cancer may be the two most common direct causes of death in the United States, but a chronic disease that now affects 29.1 million people in this country and is a prime risk factor for heart disease, cancer, and...
JNJ: 104.59 (+0.31), GWPH: 68.08 (+1.82), MRK: 57.46 (+0.25), MNKD: 5.68 (+0.18)

A New Study on Diabetes Reveals Potentially Frightening News
Sean Williams, The Motley Fool - Motley Fool - Sat Dec 20, 10:41AM CST
Based on the latest statistics from the CDC, 29.1 million people in the U.S. now have diabetes, of which more than one in four is unaware they have the chronic disease. This is up from 26 million in the CDC's last update. Further, the number of...
JNJ: 104.59 (+0.31), GWPH: 68.08 (+1.82), AZN: 70.44 (+0.26), MNKD: 5.68 (+0.18)

BreedIT and Seach Leverage Designer Strains to Better Cure
ACCESSWIRE - Thu Dec 18, 8:40AM CST
WHITEFISH, MT / ACCESSWIRE / December 18, 2014 / The benefits of medical cannabis are becoming increasingly apparent as companies like GW Pharmaceuticals plc (NASDAQ: GWPH) publish the results of the clinical trials for their cannabinoid-based medicines. For example, their Epidiolex has shown tremendous potential in treating Dravet and Lennox-Gastaut syndromes.
GWPH: 68.08 (+1.82)

U.S. Legalized Cannabis Industry Estimated to be Worth Over $2 Billion in 2014 as Licensed Medical Marijuana Operators Grow Exponentially
PR Newswire - Thu Dec 18, 7:45AM CST
The cannabis retail market is expected to reach $12 billion by 2020 as America moves towards legalized marijuana state by state. Companies in focus today are: Zoned Properties, Inc. (OTC: ZDPY), Medbox, Inc. (OTC: MDBX), GW Pharmaceuticals plc (NASDAQ: GWPH), Vape Holdings Inc. (OTC: VAPE) and Terra Tech Corp. (OTC: TRTC)
GWPH: 68.08 (+1.82)

Twitter's Favorite Biotech and Pharma Stocks
Brian Orelli, The Motley Fool - Motley Fool - Tue Dec 16, 8:21AM CST
Mark Schoenebaum, the biotech and pharmaceutical analyst at Evercore ISI, asked the Twittersphere for their favorite drug stocks going into next year. What's your favorite stock for 2015 in biotech or Pharma? — Mark Schoenebaum...
BLUE: 88.76 (+3.23), BMRN: 88.18 (+0.89), TGTX: 16.03 (+0.33), BMY: 59.15 (-0.01), MACK: 10.91 (+0.36), FMI: 23.99 (-0.10), RNA: 18.76 (+0.10), GWPH: 68.08 (+1.82), SRPT: 13.88 (+0.47), MRK: 57.46 (+0.25), NLNK: 39.08 (+1.36), ICPT: 151.49 (+5.85), THLD: 2.93 (+0.01), CEMP: 20.66 (+0.78), NVS: 93.91 (+0.66)

Nasdaq makes annual changes to Biotechnology Index
Seeking Alpha - at Seeking Alpha - Mon Dec 15, 11:36AM CST

TTPH: 38.86 (+0.53), ZSPH: 43.93 (+1.77), AMRN: 0.99 (unch), OPHT: 44.93 (+1.06), AERI: 29.49 (+1.23), ASPX: 49.93 (-0.10), CNCE: 11.76 (+0.11), ICEL: 5.74 (-0.18), GWPH: 68.08 (+1.82), AUXL: 34.40 (+0.18), RTRX: 12.92 (+0.19), RCPT: 122.05 (+4.05), AAVL: 47.30 (-1.20), AKBA: 11.23 (-0.31), EXPR: 14.96 (+0.32), RARE: 45.17 (-0.56), RLYP: 30.35 (-0.22), PETX: 17.05 (+0.42), ENTA: 49.04 (+0.06), RDUS: 37.17 (+0.11), CARA: 9.78 (+0.02), FLML: 17.01 (-0.98), ALIM: 5.43 (-0.06), ANIP: 55.24 (+1.79), ICPT: 151.49 (+5.85), RVNC: 16.65 (+0.42), POZN: 7.86 (+0.07), FPRX: 26.12 (+0.07), ZFGN: 30.99 (+0.67), CRIS: 1.29 (+0.04), QLTI: 3.72 (+0.08), PCYC: 121.84 (+1.15), PTX: 9.05 (+0.28), CLDN: 18.54 (+0.85), RIGL: 2.22 (+0.02), HPTX: 21.91 (-0.08), AMPH: 11.74 (-0.09), INO: 9.11 (-0.09), VSAR: 22.25 (-0.11), FMI: 23.99 (-0.10), TBPH: 14.84 (+0.20), XLRN: 38.80 (+0.80), MGNX: 33.00 (+0.34), INSM: 15.29 (+0.15), ONTX: 3.82 (+0.06), ALDR: 25.67 (+0.43), SAGE: 38.13 (-0.75), KITE: 51.96 (+0.45), CGEN: 8.58 (-0.17), FOLD: 7.94 (+0.06), KPTI: 37.78 (+1.28)

Annual Changes to the NASDAQ Biotechnology Index
GlobeNewswire - Mon Dec 15, 6:10AM CST
The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced the results of the annual re-ranking of the NASDAQ Biotechnology Index (Nasdaq:NBI), which will become effective prior to market open on Monday, December 22, 2014.
TTPH: 38.86 (+0.53), ZSPH: 43.93 (+1.77), AMRN: 0.99 (unch), OPHT: 44.93 (+1.06), AERI: 29.49 (+1.23), ASPX: 49.93 (-0.10), CNCE: 11.76 (+0.11), ICEL: 5.74 (-0.18), GWPH: 68.08 (+1.82), AUXL: 34.40 (+0.18), RTRX: 12.92 (+0.19), RCPT: 122.05 (+4.05), AAVL: 47.30 (-1.20), AKBA: 11.23 (-0.31), EXPR: 14.96 (+0.32), RARE: 45.17 (-0.56), ZGNX: 1.20 (+0.04), RLYP: 30.35 (-0.22), PETX: 17.05 (+0.42), ENTA: 49.04 (+0.06), RDUS: 37.17 (+0.11), CARA: 9.78 (+0.02), FLML: 17.01 (-0.98), ALIM: 5.43 (-0.06), ANIP: 55.24 (+1.79), ICPT: 151.49 (+5.85), RVNC: 16.65 (+0.42), POZN: 7.86 (+0.07), NDAQ: 48.74 (-0.40), FPRX: 26.12 (+0.07), CRIS: 1.29 (+0.04), ZFGN: 30.99 (+0.67), QLTI: 3.72 (+0.08), PCYC: 121.84 (+1.15), PTX: 9.05 (+0.28), CLDN: 18.54 (+0.85), RIGL: 2.22 (+0.02), HPTX: 21.91 (-0.08), AMPH: 11.74 (-0.09), INO: 9.11 (-0.09), VSAR: 22.25 (-0.11), FMI: 23.99 (-0.10), TBPH: 14.84 (+0.20), XLRN: 38.80 (+0.80), MGNX: 33.00 (+0.34), INSM: 15.29 (+0.15), ONTX: 3.82 (+0.06), ALDR: 25.67 (+0.43), SAGE: 38.13 (-0.75), KITE: 51.96 (+0.45), CGEN: 8.58 (-0.17), FOLD: 7.94 (+0.06), KPTI: 37.78 (+1.28)

How to Buy Great Healthcare Stocks
Todd Campbell and Michael Douglass, The Motley Fool - Motley Fool - Fri Dec 12, 12:22PM CST
Not every investor interested in the healthcare sector has personal expertise in the field. Foolish Analyst Michael Douglass and Contributor Todd Campbell share some of the perks and pitfalls of investing in healthcare companies, from retail to big...
GWPH: 68.08 (+1.82), CVS: 97.89 (+0.02), WAG: 76.67 (+0.16), RAD: 7.26 (-0.09), CELG: 109.60 (+3.48)

Covidien Loses $176M Award in Patent Case Against JNJ Unit - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 5:45PM CST
The patent infringement war between Covidien plc (COV) and Ethicon Endo-Surgery Inc. received a fresh ruling from the top U.S. patent appeals court last Thursday.
ICUI: 83.38 (+1.63), JNJ: 104.59 (+0.31), GWPH: 68.08 (+1.82), COV: 103.35 (+0.57)

RedHill submits MAA for ondansetron
Seeking Alpha - at Seeking Alpha - Tue Dec 09, 11:38AM CST

INSY: 41.52 (+0.51), TSRO: 36.80 (+0.57), HRTX: 9.75 (+0.02), RDHL: 12.22 (-0.13), GWPH: 68.08 (+1.82), OPK: 9.63 (+0.21), GALE: 1.49 (-0.02)

Why GW Pharmaceuticals Is Currently The Only Game In Town For A Cannabis Play
Nick Cox - at Seeking Alpha - Mon Dec 08, 10:59AM CST

INSY: 41.52 (+0.51), GWPH: 68.08 (+1.82)

Novus Becomes an Insurance Leader as MMJ Market Approaches Tipping Point
ACCESSWIRE - Mon Dec 08, 9:21AM CST
WHITEFISH, MT / ACCESSWIRE / December 8, 2014 / A unique company in the MMJ space today that is focused on the medical insurance side of the business is Novus Acquisition & Development (OTC: NDEV). Novus provides health insurance and insurance related solutions to the growing wellness and MMJ markets using an innovative cost-saving provider network model that is administered via their wholly-owned Novus Medical Group subsidiary's Novus MedPlan. The timely rollout of the Novus MedPlan in states where MMJ is legal, which gives patients access to considerable discounts on MMJ products for a modest subscriber fee of under $20 a month, was recently highlighted in Forbes as the number one pick, taking the top slot out of a list of the eight hottest publicly traded companies to draw the interest of investors in this rapidly emerging sector.
CARA: 9.78 (+0.02), INSY: 41.52 (+0.51), GWPH: 68.08 (+1.82)

American Cannabis Helps Navigate the Cannabis Industry
ACCESSWIRE - Mon Dec 08, 8:55AM CST
WHITEFISH, MT / ACCESSWIRE / December 8, 2014 / The U.S. cannabis industry could be worth $35 billion in 2020 if all 50 states legalized the drug and the federal government ended its prohibition, according to a report from GreenWave Advisors. Even if the federal government doesn't end prohibition and the trajectory of legalization continues on its path, the industry could still reach $20 billion in size by the analyst's estimate.
GWPH: 68.08 (+1.82), TWD.VN: 2.000 (-0.020)

American Cannabis Company, A Delaware Corporation, Joins The List Of At Least 46 Other Marijuana Stocks
Anthony Cataldo - at Seeking Alpha - Sun Dec 07, 5:36PM CST

GWPH: 68.08 (+1.82), FULL: 4.76 (-0.01)

Could Marijuana Be the Answer to Fighting This Deadly Disease?
Sean Williams, The Motley Fool - Motley Fool - Sun Dec 07, 10:41AM CST
Source: Flickr user James St. John. The midterm elections may be over, but the jockeying over marijuana's ultimate fate as a medical -- and recreational -- drug hasn't died down one bit. Marijuana's enormous market potential Over the past...
GWPH: 68.08 (+1.82), LLY: 70.16 (+0.42)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

RingConn Bets Middle-earth Fandom Can Boost Health Wearables

Updated Category News Views 102

A Familiar Gold Band Meets a Crowded Wearables Market RingConn has taken one of pop culture's most loaded objects and turned it into a health-tracking accessory, which is either clever brand work or a costly bit of cosplay depending on execution. The company unveiled The One Ring, a limited-edition version of its Gen 3 Smart Ring, through a partnership with Warner Bros....

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 120

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
Great Rail Journeys Bets Bigger on Luxury Rail in 2027

Updated Category News Views 107

A $19,995 vacation is not selling a seat on a train; it is selling relief from planning, crowds and compromise. Great Rail Journeys is leaning hard into that proposition for 2027 with two additions to its premium Landmark Collection: a Europe-heavy Orient Express and Rhône cruise pairing, plus a South Africa itinerary built around safari, Victoria Falls and rail-flavored...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 167

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Central Florida Buyers Face the Cash Reality First

Updated Category News Views 128

A house hunt can go sideways before the first showing if the buyer has confused a dream budget with a real one. Tom McKnight’s guidance for first-time buyers in Central Florida lands on the unglamorous stuff, which is exactly where it ought to land: cash, credit, financing, insurance, taxes, and the physical condition of the house. Nobody enjoys staring at lender...

Continue Reading
Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 119

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
Cloud Security’s $26.8 Billion Test Is All About Execution

Updated Category News Views 65

A cloud dashboard that spits out ten thousand alerts is not protection; it is an expensive way to make a security team miserable. That frustration sits right in the middle of Frost & Sullivan’s projection that global cloud security revenue will climb from $8.4 billion in 2025 to $26.8 billion by 2031, a 21.4% compound annual growth rate. The number is hefty, no...

Continue Reading
Surfcomber Uses Art Week to Deepen Its Guest Appeal

Updated Category News Views 82

Miami Art Week can turn every hotel lobby into a billboard, but Surfcomber is at least trying to make its walls do some actual work. Kimpton Surfcomber Hotel is spreading local artists, participatory events, food, cocktails and retail across the property rather than hanging a few paintings and calling it culture. For a South Beach hotel with 200 feet of oceanfront, that...

Continue Reading
Align Wagner Collection Tests Men's Footwear Depth

Updated Category News Views 57

Three pairs of shoes are not a revolution, but they can expose whether a young brand has its footing. Align, established in 2025 by H.H. Brown, is rolling out the Wagner collection for Fall-Winter 2026 with a waterproof boot, a penny loafer and a lace-up oxford. That is a sensible little arsenal, not some overstuffed catalog dreamed up by a marketing committee that has...

Continue Reading
Triller Lawsuit Puts Merger Disclosures Under a Harsh Light

Updated Category News Views 90

A $0.32 closing price has a way of stripping the paint off a corporate story. The proposed securities class action involving Triller Group, Inc. puts a hard spotlight on a familiar, ugly market sequence: a splashy merger, glowing talk around acquired assets, delayed financial filings, Nasdaq trouble, and then a collapse severe enough to leave shareholders wondering what...

Continue Reading

Top 5 Most Recently Viewed Articles

Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 420

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
BW LPG Limited Welcomes BW Chinook: A Significant Milestone

Updated Category News Views 180

Significant Acquisition by BW LPG Limited BW LPG Limited has recently taken a remarkable step in enhancing its fleet and operational capabilities. The company announced the acquisition of the vessel BW Chinook, marking an important milestone in its ongoing strategy to strengthen its position in the global LPG market. Details of the Vessel Delivery Following a stock...

Continue Reading
COMAC's Expansion: New Hong Kong Office and Maintenance Deal

Updated Category News Views 175

COMAC's Global Expansion Efforts Chinese planemaker COMAC has taken a significant step in its quest to enter the global passenger jet market by inaugurating its second international office in Hong Kong. This move aligns with their strategy to provide enhanced services and establish a stronger footprint outside mainland China. The opening not only symbolizes growth but...

Continue Reading
Torrid Holdings CEO Lisa Harper Makes Strategic Stock Move

Updated Category News Views 415

Lisa Harper's Recent Sale of Company Shares Lisa Harper, the CEO of Torrid Holdings Inc. (NYSE: CURV), has recently sold shares worth $283,909, according to a filing with the Securities and Exchange Commission. In this transaction, she sold 74,713 shares at a price of $3.80 each. This sale is part of her exercise of the underwriters' option to purchase additional shares...

Continue Reading
Getty Images Plans Q3 2024 Financial Results Release Date

Updated Category News Views 102

Getty Images Announces Q3 2024 Financial Results Date Getty Images Holdings, Inc. (NYSE: GETY), a leader in the global visual content industry, is gearing up to share its financial results for the third quarter of 2024. The results will be unveiled right after market closing on November 7, 2024. This announcement signals an important moment for stakeholders keeping a...

Continue Reading